Macrocyclic alkene containing bisimidazole showing molecular asymmetry, which is synthesized by ring-closing metathesis, is subjected to several functional group transformation reactions of the olefin moiety. Syn-addition reactions such as epoxidation, dihydroxylation, and hydrogenation are found to proceed whereas anti-addition does not proceed. Optical resolution of racemic bisimidazole is successfully achieved with a preparative chiral column. Racemization behaviors of bisimidazole derivatives are also studied under several conditions.
Molecular asymmetry, which does not involve stereogenic carbon but exhibits chirality, attracts considerable attention in a wide range of organic chemistry. 1 In particular, axially-chiral biaryl derivatives are known as a valuable catalyst in organocatalysis as well as ligands for a wide variety of metalcatalyzed asymmetric synthesis to induce chirality onto organic molecules by si/re face selection to sp 2 carbon, 2 desymmetrization of prochiral bifunctional compounds, kinetic resolution based on a chiral carbogenic center, etc. 3 We have recently reported that ring-closing metathesis (RCM) 4 of a bisbenzimidazole derivative bearing an ω-olefinic substituent at the nitrogen atom 1 leads to the formation of macrocyclic alkene 2, which shows novel molecular asymmetry, as shown in Scheme 1. 5 The chirality is axially chiral caused by the restriction of free rotation of the carboncarbon bond between imidazole rings by ring closure. 6 It is also recognized as helical chirality by the left or right-handed helicity of the alkylene chain between bisimidazole rings 7 as morning glory vine propagates along with a supporting bar composed of rigid (hetero)biaryl. In addition, the carboncarbon double bond formed by RCM would also induce facial chirality, 8 one of whose face is covered with the bisimidazole structure. Thus, 2 showing chirality is categorized as a new class of molecular asymmetry, which has not been reported so far, named winding-vine-shaped molecular asymmetry. 9 The structure of the RCM product was clarified by X-ray crystal structure analysis, which showed formation of enantiopair in the single crystal, and that the molecule was shown to be separated analytically by HPLC with a chiral column. Accordingly, our concern is turned to further understanding of such novel molecular asymmetry. 5, 9 We herein describe transformation of the olefinic moiety to introduce functional groups, optical resolution of the thus formed racemic 2 with a preparative chiral column, and racemization behaviors of 2 and the derivatives.
Results and Discussion
We first set out studies on the functionalization of the olefin moiety of 2 formed by ring-closing metathesis with a ruthenium catalyst. Several addition reactions at the carboncarbon double bond can be designed as summarized in Scheme 2. When macrocyclic bisimidazole 2 was treated with oxone (NaHSO 5 ) in acetone/water (1:1), the corresponding epoxide 3 was obtained in 62% yield. 10 Since the reaction is well known to proceed in a syn-addition manner by the in situ formed dioxirane derived from acetone, the thus formed two stereogenic centers in 3 would possibly form diastereomeric isomers. However, HPLC analysis of 3 with a chiral column only displayed two detectable peaks based on the racemate and 1 H NMR analysis did not suggest the presence of diastereoisomers. Dihydroxylation proceeded catalyzed by potassium osmate (K 2 OsO 4 ¢H 2 O) (10 mol %) in the presence of Nmethylmorpholine N-oxide (NMO) as an oxidant to give cisdiol 4 in 90% yield. 11 The diasteroisomer of 4 was not observed by 1 H NMR analyses similar to the case of 3. Hydrogenation was also found to take place with Pd/C as a catalyst under hydrogen atmosphere (1 atm) to afford saturated product 5 in 96% yield, 12 whose facial chirality arising from the CC double bond disappeared but may still involve potential helical and axial chiralities whereas separation of the racemate of 5 has not been achieved by HPLC with a chiral column. On the other hand, addition of iodine to the double bond of 2 did not occur at all to result in recovery of the starting material.
These reactions suggested that syn-addition to the carbon carbon double bond occurred smoothly whereas the reaction known to proceed in an anti-addition manner did not take place. The results would be caused by the effective block of a face of the carboncarbon double bond by bisimidazole rings albeit possible formation of iodonium salt on the unblocked face of olefin. The shielded bisbenzimidazole moiety would not allow the resulting attack of iodide ion, bringing about no reaction. Attempted ring opening of epoxide 3 with Me 2 CuLi, 13 which would proceed by the attack of the methyl group in a S N 2 manner leading to the ring-opened product, was also examined to result in no reaction (recovery of 60% 3) as shown in Scheme 2 (ii).
In addition to analytical HPLC of 2 with a chiral column to separate two peaks of the racemic mixture, separation of the enantiomer with a preparative chiral column has also been successful to result in clear base-line separation to isolate isomers of faster elute (+)-2 ([α] D = +136°) and the second (¹)-2 ([α] D = ¹145°). 9 Although X-ray analysis to clarify crystal structure of each enantiomer had been attempted, it was found that the separated enantiomer showed amorphous characteristics and thus caused difficulties in obtaining a single crystal of (+)-or (¹)-2. 14 Indeed, XRD analysis of the enantiopure 2 only showed broad signals, while that of the racemate («)-2 indicated sharp peaks suggesting the good crystallinity as shown in Figure 1a and Figure 1b . Measurement of circular dichroism (CD) spectra was also performed as shown in Figure 2 . Both peaks of each enantiomer showed symmetric signals to suggest that the two separated products are actually both enantiomers of 2. The CD spectra indicated positive Cotton effect in (+)-2 and the negative one in (¹)-2 at ca. 290 nm, respectively, and the peaks are close to the max of the UV vis spectrum of 2 ( Figure 2 ).
We also studied racemization behaviors of bisimidazole derivatives of molecular asymmetry. Accompanied by bisbenzimidazole 2 several other bisimidazole derivatives were also prepared and subjected to resolution with a chiral column. Macrocyclic alkene 6 composed of 4,5-dibromoimidazole rings was prepared from 2,4,5-tribromoimidazole through N-alkylation with 4-bromo-1-butene followed by debrominative homocoupling leading to the metathesis precursor. The RCM reaction of the thus obtained product afforded the correspond- ing 4,4¤,5,5¤-tetrabromobisimidazole 6. 9 Resolution was then carried out in a similar manner with preparative chiral column (DAICEL CHIRALPAK-IF) to afford (+)-and (¹)-6. The separated enantiomers exhibited [α] D values of +54°((+)-6) and [α] D = ¹51°((¹)-6), respectively. Furthermore, several functional group transformations were also conducted with the optically active 6. Cross coupling with arylboronic acid was carried out as reported previously with slight racemization to afford 7 in 91% ee. 9, 15, 16 Treatment of 6 with two equivalents of Grignard reagent EtMgCl underwent the 4,4¤-selective debrominative protonation via halogenmetal exchange leading to 8, 17 in which decrease of the optical purity was hardly observed under the reaction conditions. The enantioenriched epoxide 3 was obtained by oxidation of the resolved 2 (Scheme 3).
The obtained bisimidazole derivatives were thereby subjected to study racemization behaviors. Macrocyclic compounds 2, 3, 6, 7, and 8 were heated at 80, 100, and 140°C, respectively, in 1,2-dichloroethane or chlorobenzene. Figures 3a3c shows the relationship of the enantiomeric excess of the bisimidazole derivatives with the time conversion, which were analyzed by HPLC (DAICEL CHIRALPAK IF), at each temperature. Enantiomeric excess of bisbenzimidazole 2, tetrakis(tolylated)bisimidazole 7, and 4,4¤-dibromobisimidazole 8 were found to decrease slowly at 80°C. In contrast, little racemization of epoxide 3 and tetrabromobisimidazole 6 was observed. When the temperature was raised to 100°C, 2, 7, and 8 racemized faster than those at 80°C. By contrast, the enantiopurities of 3 and 6 were kept higher even after 24 h. Racemization of 2, 7, and 8 occurred immediately at 140°C while that of 6 was relatively slower. It should be pointed out that enantiomeric excess of 3 bearing epoxide did not decrease at all even at such a high temperature with a marked contrast to other bisimidazole derivatives. Considering the racemization of bisimidazole derivatives, inversion of facial chirality is induced along with rotation of azoleazole bond as well as helicity of the alkylene chain. 19 Introduction of the epoxy ring to the olefin moiety would inhibit rotation of the epoxy ring into the proximal side to the imidazole rings because of steric repulsion compared with the corresponding CC double bond and thus rotation of the imidazoleimidazole bond was not induced, accordingly.
Although attempted racemization studies of 5 has not yet been achieved due to analytical difficulties by HPLC with a chiral column, racemization of 5 would be easier than that of 2 bearing olefin probably because of more flexible rotation of sp 3 methylene groups.
Conclusion
In summary, we have shown that functional group transformations of olefin moiety of novel bisimidazole derivatives of molecular asymmetry are achieved with several addition reactions that proceed in a syn manner. These addition reactions were suggested to proceed diastereoselectively because of the steric barrier caused by aromatic rings of bisimidazole. Successful resolution of the enantiomer of macrocyclic bisimidazole derivatives with a chiral column was shown in a preparative manner to isolate enantiopure bisbenzoimidazole and tetrabrominated bisimidazole. Studies on racemization behaviors revealed that several imidazole derivatives do not racemize up to 80°C and slow racemization started to occur whereas the rate of racemization depended on the structure. Introducing epoxide to this macrocyclic alkene remarkably inhibited the racemization due to increasing of the activation energy for the rotation of the azoleazole bond. These results provide deeper understanding of the nature of a series of winding-vine-shaped molecular asymmetric compounds and further molecular design of such derivatives.
Experimental
General. NMR spectra were measured on a BRUKER Avance-500 (500 MHz for 1 H; 125 MHz for 13 C) at the Center for Support of Research and Education Activities of Kobe University. The chemical shifts are expressed in ppm with CDCl 3 (7.26 ppm for 1 H; 77.0 ppm for 13 C), DMSO-d 6 (2.54 ppm for 1 H; 39.5 ppm for 13 C) as internal standards. IR spectra were recorded on a Bruker Alpha with an ATR attachment (Ge). UV spectrum was measured by an ALS SEC-2000 UV/ vis spectrometer. High resolution mass spectra (HRMS) were measured on a JEOL JMS-T100LP AccuTOF LC-Plus (ESI) with a JEOL MS-5414DART attachment. HPLC analysis was carried out with a JASCO LC-2000 Plus with chiral column Daicel Chiralpak IF (0.46 cm I.D. © 25 cm, flow rate: 1.0 mL min ¹1 ) using hexane/ethanol (1:1) as an eluent and UV (254 nm) detector. Optical rotation was measured on a Horiba SEPA-300 polarimeter or JASCO P-2100 as a solution in a 1 dm 3 cell. CD spectrum was measured on a JASCO J-820 spectrometer. XRD analysis was carried out with a RINT-Ultima+2200. For thin layer chromatography (TLC) analyses throughout this work, Merck precoated TLC plates (silica gel To a 25 mL Schlenk tube equipped with a magnetic stirring bar were added macrocyclic alkene 2 (31.4 mg, 0.1 mmol), anhydrous acetone (0.5 mL), and water (0.5 mL) under air atmosphere at room temperature. Then oxone (123 mg, 0.2 mmol) was added and stirring was continued for 12 h at 60°C to confirm completion of the reaction by TLC analysis. Water was added to quench the reaction and the organic layer was separated. The aqueous layer was extracted with dichloromethane and the combined organic layers were dried over anhydrous magnesium sulfate. The solution was concentrated under reduced pressure to leave a crude solid, which was purified by flash column chromatography on silica gel using hexane/isopropyl acetate (1:1) as an eluent to afford the corresponding epoxide 3 (20.6 mg, 62%). IR (ATR): 3053, 2963, 2925, 1484, 1460, 1421, 1382, 1357, 1333, 1283, 1246, 1185, 1157, 1134, 1007, 962, 922, 878, 798, 748 4, 40.5, 54.8, 110.1, 120.8, 123.4, 124.4, 134.0, 142.6, 143.5 Dihydroxylation of Macrocyclic Alkene 2. To a 25 mL Schlenk tube equipped with a magnetic stirring bar were added K 2 OsO 4 ¢H 2 O (4 mg, 0.01 mmol), NMO (62.5¯L, 0.3 mmol) anhydrous acetone (0.5 mL), and water (0.5 mL) under air atmosphere at room temperature. Then macrocyclic alkene 2 (62.8 mg, 0.2 mmol) was added and stirring was continued for 12 h at room temperature to confirm completion of the reaction by TLC analysis. Water was added to quench the reaction and the organic layer was separated. The aqueous layer was extracted with dichloromethane and the combined organic layers were dried over anhydrous magnesium sulfate. The solution was concentrated under reduced pressure to leave a crude solid, which was purified by flash column chromatography on silica gel using dichloromethane/MeOH (10:1) as an eluent to afford the corresponding 4 (62.7 mg, 90%). Attempted HPLC analysis with a chiral column has not been successful so far. IR (ATR): 3330, 2929, 1464, 1417, 1369, 1281, 1240, 1202, 1167, 1158, 1124, 1098, 1064, 1019, 933, 902, 844, 811, 799 40.9, 62.9, 112.1, 120.2, 123.1, 124.0, 133.8, 142.7, 144. Hydrogenation of Macrocyclic Alkene 2. To a 25 mL Schlenk tube equipped with a magnetic stirring bar were added macrocyclic alkene 2 (31.4 mg, 0.1 mmol), Pd/C (10.6 mg 0.01 mmol), and anhydrous methanol (1.0 mL), under nitrogen atmosphere at room temperature. Then stirring was continued for 20 h at room temperature under H 2 atmosphere to confirm completion of the reaction by NMR analysis. The reaction solution was purified by flash column chromatography on silica gel using hexane/ethyl acetate (1:1) as an eluent to afford the corresponding macrocyclic alkane 5 (30.6 mg, 96%). IR (ATR): 2940, 1468, 1457, 1427, 1416, 1364, 1330, 1281, 1245, 1166, 746, 721 , 664 cm ¹1 . 1 H NMR (500 MHz, CDCl 3 ): ¤ 0.22 (d, J = 11.4 Hz, 2H), 0.951.10 (br, 2H), 1.36 (t, J = 13.5 Hz, 2H), 2.002.12 (m, 2H), 4. 354.44 (m, 4H), 7.347.42 (m, 4H), 7.467.51 (m, 2H), 7.867.91 (m, 2H) 13 C NMR (125 MHz, CDCl 3 ): ¤ 25. 6, 32.8, 41.4, 110.9, 120.8, 123.0, 123.8, 133.8, 143.2, 144.8. HRMS (DART+) calcd. for C 20 H 21 N 4
Preparation of Di([d]-4,5-dibromoimidazo)[1,2-a:2,1-c]-1,8-diaza-7-(E)-cyclodecene 6. To a 25 mL Schlenk tube equipped with a magnetic stirring bar were added 4,4¤,5,5¤tetrabromobisimidazole (0.83 g, 1.5 mmol) and 1,2-dichloroehtane (15 mL) under a nitrogen atmosphere at room temperature. Then, ZnI 2 (95 mg, 0.30 mmol) was added and stirring was continued for 0.5 h at room temperature. Grubbs 2nd generation catalyst (63 mg, 0.075 mmol) was added and the resulting mixture was stirred for 24 h at 80°C. The reaction was confirmed to be complete by TLC analysis. Water was added to quench the reaction and the organic layer was separated. The aqueous layer was extracted with chloroform and the combined organic layers were dried over anhydrous magnesium sulfate. The solution was concentrated under reduced pressure to leave a crude solid, which was purified by flash column chromatography on silica gel using hexane/isopropyl alcohol (5:1) as an eluent to afford 6 (42 mg, 50%). IR (ATR): 2962, 2922, 1482, 1454, 1438, 1412, 1394, 1383, 1357, 1328, 1287, 1229, 1206, 1158, 1105, 1095, 1071, 1005, 973, 923, 908, 886, 802, 729, 680, 646, 628 , 616 cm ¹1 . 1 H NMR (500 MHz): ¤ 1.902.02 (m, 2H), 2.262.34 (m, 2H), 4.134.31 (m, 4H), 4.404.52 (m, 2H) . 13 C NMR (125 MHz): ¤ 33.1, 45.8, 105.4, 116.7, 129.0, 139.5. HRMS (DART+) Preparation of (¹)-Di([d]-4,5-di(4-methyphenyl)imidazo)-[1,2-a:2,1-c]1,8-diaza-7(E)-cyclodecene 7.
To a 25 mL Schlenk tube equipped with a magnetic stirring bar were added [Pd 2 (dba) 3 ]¢CHCl 3 (14 mg, 0.014 mmol), PPh 3 (29 mg, 0.11 mmol), and anhydrous DMF (0.5 mL) under a nitrogen atmosphere at room temperature. After stirring for 0.5 h at room temperature, chiral (¹)-6 (49 mg, 0.092 mmol, 99% ee), which was separated with a preparative chiral column (Daicel Chiralpak IF) using hexane/ethanol = 1:1 as an eluent, dissolved in 1.0 mL of DMF was added to the mixture. Then, 4methylphenylboronic acid pinacol ester (0.120 g, 0.55 mmol) and potassium carbonate (0.10 g, 0.73 mmol) were added. Further stirring was continued for 90 h at 80°C and completion of the reaction was confirmed by TLC analysis. Water was added to quench the reaction and the organic layer was separated. The aqueous layer was extracted with chloroform and the combined organic layers were dried over anhydrous magnesium sulfate. The solution was concentrated under reduced pressure to leave a crude oil, which was purified by flash column chromatography on silica gel using hexane/ isopropyl acetate (5:1) as an eluent to afford the corresponding coupling product (¹)-7 (30 mg, 52%). The enantioselectivity was estimated by HPLC analysis with a chiral column (Daicel IF) using hexane/ethanol = 1:1 as an eluent to exhibit 91% ee. ½ 24 D ¼ À76:8 (c 1.0, CHCl 3 ); IR (ATR): 3022, 2963, 2920, 1558, 1543, 1520, 1492, 1545, 1422, 1405, 1373, 1354, 1338, 1323, 1232, 1204, 1183, 1120, 974, 963, 823, 739 To a 25 mL Schlenk tube equipped with a magnetic stirring bar were added chiral macrocyclic alkene (¹)-6 (38.5 mg, 0.073 mmol, 99% ee) and anhydrous tetrahydrofuran (THF) under nitrogen atmosphere at room temperature. Then 0.93 M EtMgCl in THF was added slowly at 0°C, and the resulting mixture was stirred for 5 h at room temperature. Water was added to the reaction mixture to stop the reaction and the organic layer was extracted with chloroform. After concentration under reduce pressure, the residue was purified by flash column chromatography on silica gel using hexane/iPrOAc (1:1) as an eluent to afford the corresponding (+)-8 (15.7 mg, 58%). The enantioselectivity was estimated by HPLC analysis with a chiral column (Daicel Chiralpak IF) using hexane/ethanol = 1:1 as an eluent to exhibit 93% ee. IR (ATR): 3137, 2919, 2850, 1500, 1455, 1421, 1407, 1394, 1354, 1289, 1240, 1158, 1122, 1055, 1004, 980, 956, 926, 802, 755, 741 To a 25 mL Schlenk tube equipped with a magnetic stirring bar were added chiral macrocyclic alkene 2 (31.4 mg, 0.1 mmol, 99% ee) and CHCl 3 (1.0 mL) under aerobic atmosphere at 60°C. Then, mCPBA (54 mg, 0.5 mmol) was added and stirring was continued for 16 h at 60°C to confirm completion of the reaction by TLC analysis. Water was added to quench the reaction and the organic layer was separated. The aqueous layer was extracted with dichloromethane and the combined organic layers were dried over anhydrous magnesium sulfate. The solution was concentrated under reduced pressure to leave a crude solid, which was purified by flash column chromatography on silica gel using hexane/isopropyl acetate (1:1) as an eluent to afford the corresponding epoxide 3 (11.6 mg, 35%). The enantioselectivity was estimated by HPLC analysis with a chiral column (Daicel IF) using hexane/ethanol = 1:1 as an eluent to exhibit 99% ee. ½ 24 D ¼ þ41:4 (c 0.39 CHCl 3 ).
